Genus plc Stock
A very strong showing by Genus plc today, with an increase of €0.80 (3.200%) compared to yesterday's price.
Pros and Cons of Genus plc in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Genus plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Genus plc | 3.200% | 4.878% | 5.738% | -7.857% | -12.245% | -9.091% | -58.720% |
| Ligand Pharmaceuticals | -0.760% | -2.985% | -2.256% | 122.222% | 56.627% | 322.764% | 155.027% |
| United Therapeutics | -0.950% | -2.150% | -3.485% | 78.733% | 7.582% | 106.607% | 194.679% |
| Ionis Pharmaceuticals Inc. | -2.520% | 3.737% | -31.884% | 36.807% | -28.517% | 34.571% | 52.575% |
Comments
Genus (OTCMKTS:GENSF) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for GENSF provided by MarketBeat